Dopamine supersensitivity psychosis (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dopamine supersensitivity psychosis" in English language version.

refsWebsite

Global rank English rank

15nih.gov

4^th place

10doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

1worldcat.org

5^th place

1time.com

61^st place

54^th place

1scientificamerican.com

896^th place

674^th place

1nybooks.com

1,785^th place

1,133^rd place

doi.org

Nakata, Y; Kanahara, N; Iyo, M (December 2017). "Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice". Journal of Psychopharmacology. 31 (12): 1511–1518. doi:10.1177/0269881117728428. PMID 28925317. S2CID 1957881.
Yin, John; Barr, Alasdair; Ramos-Miguel, Alfredo; Procyshyn, Ric (14 December 2016). "Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review". Current Neuropharmacology. 15 (1): 174–183. doi:10.2174/1570159X14666160606093602. PMC 5327459. PMID 27264948.
Seeman, Philip (April 2011). "All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors". CNS Neuroscience & Therapeutics. 17 (2): 118–132. doi:10.1111/j.1755-5949.2010.00162.x. PMC 6493870. PMID 20560996.
Brisch, Ralf; Saniotis, Arthur; Wolf, Rainer; Bielau, Hendrik; Bernstein, Hans-Gert; Steiner, Johann; Bogerts, Bernhard; Braun, Anna Katharina; Jankowski, Zbigniew; Kumaritlake, Jaliya; Henneberg, Maciej; Gos, Tomasz (19 May 2014). "The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue". Frontiers in Psychiatry. 5: 47. doi:10.3389/fpsyt.2014.00047. PMC 4032934. PMID 24904434.
Karaş, Hakan; Güdük, Mehmet; Saatcioğlu, Ömer (June 2016). "Withdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use". Noro Psikiyatri Arsivi. 53 (2): 178–180. doi:10.5152/npa.2015.10122. ISSN 1300-0667. PMC 5353025. PMID 28360793.
Chouinard G, Jones BD, Annable L (1978). "Neuroleptic-induced supersensitivity psychosis". Am J Psychiatry. 135 (11): 1409–10. doi:10.1176/ajp.135.11.1409. PMID 30291.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Palmstierna, T; Wistedt, B (1988). "Tardive psychosis: Does it exist?". Psychopharmacology. 94 (1): 144–5. doi:10.1007/BF00735897. PMID 2894699. S2CID 29048614.
Kirkpatrick B, Alphs L, Buchanan RW (1992). "The concept of supersensitivity psychosis". J Nerv Ment Dis. 180 (4): 265–70. doi:10.1097/00005053-199204000-00009. PMID 1348269. S2CID 29597822.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Chouinard G (1991). "Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment". Schizophr Res. 5 (1): 21–33. doi:10.1016/0920-9964(91)90050-2. PMID 1677263. S2CID 38211914.
Fallon, P; Dursun, S; Deakin, B (February 2012). "Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients". Therapeutic Advances in Psychopharmacology. 2 (1): 13–22. doi:10.1177/2045125311431105. PMC 3736929. PMID 23983951.

nih.gov

pubmed.ncbi.nlm.nih.gov

Nakata, Y; Kanahara, N; Iyo, M (December 2017). "Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice". Journal of Psychopharmacology. 31 (12): 1511–1518. doi:10.1177/0269881117728428. PMID 28925317. S2CID 1957881.
Yin, John; Barr, Alasdair; Ramos-Miguel, Alfredo; Procyshyn, Ric (14 December 2016). "Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review". Current Neuropharmacology. 15 (1): 174–183. doi:10.2174/1570159X14666160606093602. PMC 5327459. PMID 27264948.
Seeman, Philip (April 2011). "All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors". CNS Neuroscience & Therapeutics. 17 (2): 118–132. doi:10.1111/j.1755-5949.2010.00162.x. PMC 6493870. PMID 20560996.
Brisch, Ralf; Saniotis, Arthur; Wolf, Rainer; Bielau, Hendrik; Bernstein, Hans-Gert; Steiner, Johann; Bogerts, Bernhard; Braun, Anna Katharina; Jankowski, Zbigniew; Kumaritlake, Jaliya; Henneberg, Maciej; Gos, Tomasz (19 May 2014). "The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue". Frontiers in Psychiatry. 5: 47. doi:10.3389/fpsyt.2014.00047. PMC 4032934. PMID 24904434.
Karaş, Hakan; Güdük, Mehmet; Saatcioğlu, Ömer (June 2016). "Withdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use". Noro Psikiyatri Arsivi. 53 (2): 178–180. doi:10.5152/npa.2015.10122. ISSN 1300-0667. PMC 5353025. PMID 28360793.
Chouinard G, Jones BD, Annable L (1978). "Neuroleptic-induced supersensitivity psychosis". Am J Psychiatry. 135 (11): 1409–10. doi:10.1176/ajp.135.11.1409. PMID 30291.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Palmstierna, T; Wistedt, B (1988). "Tardive psychosis: Does it exist?". Psychopharmacology. 94 (1): 144–5. doi:10.1007/BF00735897. PMID 2894699. S2CID 29048614.
Kirkpatrick B, Alphs L, Buchanan RW (1992). "The concept of supersensitivity psychosis". J Nerv Ment Dis. 180 (4): 265–70. doi:10.1097/00005053-199204000-00009. PMID 1348269. S2CID 29597822.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Chouinard G (1991). "Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment". Schizophr Res. 5 (1): 21–33. doi:10.1016/0920-9964(91)90050-2. PMID 1677263. S2CID 38211914.
Fallon, P; Dursun, S; Deakin, B (February 2012). "Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients". Therapeutic Advances in Psychopharmacology. 2 (1): 13–22. doi:10.1177/2045125311431105. PMC 3736929. PMID 23983951.

ncbi.nlm.nih.gov

Yin, John; Barr, Alasdair; Ramos-Miguel, Alfredo; Procyshyn, Ric (14 December 2016). "Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review". Current Neuropharmacology. 15 (1): 174–183. doi:10.2174/1570159X14666160606093602. PMC 5327459. PMID 27264948.
Seeman, Philip (April 2011). "All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors". CNS Neuroscience & Therapeutics. 17 (2): 118–132. doi:10.1111/j.1755-5949.2010.00162.x. PMC 6493870. PMID 20560996.
Brisch, Ralf; Saniotis, Arthur; Wolf, Rainer; Bielau, Hendrik; Bernstein, Hans-Gert; Steiner, Johann; Bogerts, Bernhard; Braun, Anna Katharina; Jankowski, Zbigniew; Kumaritlake, Jaliya; Henneberg, Maciej; Gos, Tomasz (19 May 2014). "The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue". Frontiers in Psychiatry. 5: 47. doi:10.3389/fpsyt.2014.00047. PMC 4032934. PMID 24904434.
Karaş, Hakan; Güdük, Mehmet; Saatcioğlu, Ömer (June 2016). "Withdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use". Noro Psikiyatri Arsivi. 53 (2): 178–180. doi:10.5152/npa.2015.10122. ISSN 1300-0667. PMC 5353025. PMID 28360793.
Fallon, P; Dursun, S; Deakin, B (February 2012). "Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients". Therapeutic Advances in Psychopharmacology. 2 (1): 13–22. doi:10.1177/2045125311431105. PMC 3736929. PMID 23983951.

nybooks.com

Angell, Marcia. "The Epidemic of Mental Illness: Why?". New York Review of Books.

scientificamerican.com

blogs.scientificamerican.com

"Are Psychiatric Medications Making Us Sicker?". Scientific American.

semanticscholar.org

api.semanticscholar.org

Nakata, Y; Kanahara, N; Iyo, M (December 2017). "Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice". Journal of Psychopharmacology. 31 (12): 1511–1518. doi:10.1177/0269881117728428. PMID 28925317. S2CID 1957881.
Palmstierna, T; Wistedt, B (1988). "Tardive psychosis: Does it exist?". Psychopharmacology. 94 (1): 144–5. doi:10.1007/BF00735897. PMID 2894699. S2CID 29048614.
Kirkpatrick B, Alphs L, Buchanan RW (1992). "The concept of supersensitivity psychosis". J Nerv Ment Dis. 180 (4): 265–70. doi:10.1097/00005053-199204000-00009. PMID 1348269. S2CID 29597822.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Chouinard G (1991). "Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment". Schizophr Res. 5 (1): 21–33. doi:10.1016/0920-9964(91)90050-2. PMID 1677263. S2CID 38211914.

time.com

content.time.com

Fitzpatrick, Laura (3 May 2010). "Book review: Anatomy of an Epidemic by Robert Whitaker". Time.

worldcat.org

Karaş, Hakan; Güdük, Mehmet; Saatcioğlu, Ömer (June 2016). "Withdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use". Noro Psikiyatri Arsivi. 53 (2): 178–180. doi:10.5152/npa.2015.10122. ISSN 1300-0667. PMC 5353025. PMID 28360793.